Rosiglitazone monotherapy in mild-to-moderate Alzheimers disease: results from a randomized, double-blind, placebo-controlled phase III study
Embla coaches work with members to: Set achievable goals and build consistency in daily behaviors Identify and defuse unhelpful thoughts and food-related coping patterns Prepare for plateaus and relapses and navigate through them Develop the confidence and skills to maintain weight loss for life Real-world outcomes: what employers should expect Employers implementing coaching-first models like Embla's can expect: Improved medication efficiency members use lower doses and taper sooner, which reduces total drug spend Higher engagement and adherence weekly video coaching drives strong retention and satisfaction Lower long-term costs less reliance on high-cost GLP-1s, fewer comorbidities, and healthier employee populations Transparent reporting dashboards that track individual and population-level outcomes, including weight loss, medication usage, and program ROI We've worked with employers where 8085% of members stay engaged for 6+ months, and more than half continue engaging after medication has ended because they've built a trusted relationship with their coach
We want to hear it!
and BAGSVRD, Denmark, Oct
But Part D IS required to cover GLP-1s when prescribed for medical conditions like diabetes, sleep apnea, or liver disease
Consumer food choices are evolving, and brands are adapting to remain relevant
